Stock SBBP STRONGBRIDGE BIOPHARMA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Strongbridge Biopharma

Equities

SBBP

IE00BYZ5XL97

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from S&P Global BMI Index
CI
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from S&P TMI Index
CI
STRONGBRIDGE BIOPHARMA PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
GL
Strongbridge Biopharma : plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
GL
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from NASDAQ Composite Index
CI
Xeris Pharmaceuticals, Inc. completed the acquisition of Strongbridge Biopharma plc from HealthCap VI L.P., a fund managed by Odlander, Fredrikson & Co. AB, Caxton Alternative Management LP, and others.
CI
Strongbridge Biopharma : Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
AQ
Xeris Pharmaceuticals : Shareholders Approve Pending Strongbridge Biopharma Acquisition
MT
Strongbridge Biopharma : Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc (Form 8-K)
PU
STRONGBRIDGE BIOPHARMA PLC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
GL
Strongbridge Biopharma : Says Glass Lewis Recommends Shareholders Vote in Favor of Proposed Deal with Xeris
MT
Xeris Pharmaceuticals : Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
AQ
Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
PU
STRONGBRIDGE BIOPHARMA PLC : Other Events (form 8-K)
AQ
Xeris Pharmaceuticals : ISS Recommends Xeris, Strongbridge Shareholders Vote in Favor of Proposed Deal
MT
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
GL
STRONGBRIDGE BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Strongbridge Biopharma: Q2 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SBBP Stock
  4. News Strongbridge Biopharma